苏州弘森药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
179
NMPA:179
Drug Approvals
Salbutamol Sulfate Injection
- Product Name
- 硫酸沙丁胺醇注射液
- Approval Number
- 国药准字H20258066
- Approval Date
- Apr 21, 2025
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20244847
- Approval Date
- Sep 10, 2024
NMPA
Ipratropium Bromide Solution for Inhalation
- Product Name
- 吸入用异丙托溴铵溶液
- Approval Number
- 国药准字H20244846
- Approval Date
- Sep 10, 2024
NMPA
Compound Ipratropium Bromide Solution For Inhalation
- Product Name
- 吸入用复方异丙托溴铵溶液
- Approval Number
- 国药准字H20244765
- Approval Date
- Aug 27, 2024
NMPA
Amiodarone Hydrochloride Injection
- Product Name
- 盐酸胺碘酮注射液
- Approval Number
- 国药准字H20244526
- Approval Date
- Jul 30, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20244224
- Approval Date
- Jun 28, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 18
- Next
Clinical Trials
No trials found
News
No news found